Alcon Inc. Reports Strong Q1 Performance Amid Reduced Price Target
Alcon Inc. (ALC) reported first-quarter sales of $2.7 billion with a 6% increase in constant currency, driven by new product launches and strong demand for dry eye treatments. However, Barclays reduced its price target from $90 to $78 while maintaining an Equal Weight rating.
Topics: Alcon Inc. eye care industry price target reduction Q1 earnings